These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12030893)

  • 1. Cardiomyopathy in congenital complete lipodystrophy.
    Bhayana S; Siu VM; Joubert GI; Clarson CL; Cao H; Hegele RA
    Clin Genet; 2002 Apr; 61(4):283-7. PubMed ID: 12030893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy.
    Van Maldergem L; Magré J; Khallouf TE; Gedde-Dahl T; Delépine M; Trygstad O; Seemanova E; Stephenson T; Albott CS; Bonnici F; Panz VR; Medina JL; Bogalho P; Huet F; Savasta S; Verloes A; Robert JJ; Loret H; De Kerdanet M; Tubiana-Rufi N; Mégarbané A; Maassen J; Polak M; Lacombe D; Kahn CR; Silveira EL; D'Abronzo FH; Grigorescu F; Lathrop M; Capeau J; O'Rahilly S
    J Med Genet; 2002 Oct; 39(10):722-33. PubMed ID: 12362029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.
    Agarwal AK; Simha V; Oral EA; Moran SA; Gorden P; O'Rahilly S; Zaidi Z; Gurakan F; Arslanian SA; Klar A; Ricker A; White NH; Bindl L; Herbst K; Kennel K; Patel SB; Al-Gazali L; Garg A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4840-7. PubMed ID: 14557463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.
    Magré J; Delépine M; Khallouf E; Gedde-Dahl T; Van Maldergem L; Sobel E; Papp J; Meier M; Mégarbané A; Bachy A; Verloes A; d'Abronzo FH; Seemanova E; Assan R; Baudic N; Bourut C; Czernichow P; Huet F; Grigorescu F; de Kerdanet M; Lacombe D; Labrune P; Lanza M; Loret H; Matsuda F; Navarro J; Nivelon-Chevalier A; Polak M; Robert JJ; Tric P; Tubiana-Rufi N; Vigouroux C; Weissenbach J; Savasta S; Maassen JA; Trygstad O; Bogalho P; Freitas P; Medina JL; Bonnicci F; Joffe BI; Loyson G; Panz VR; Raal FJ; O'Rahilly S; Stephenson T; Kahn CR; Lathrop M; Capeau J;
    Nat Genet; 2001 Aug; 28(4):365-70. PubMed ID: 11479539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy.
    Zhou H; Lei X; Yan Y; Lydic T; Li J; Weintraub NL; Su H; Chen W
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31185001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe cardiac phenotype of Berardinelli-Seip congenital lipodystrophy in an infant with homozygous E189X BSCL2 mutation.
    Friguls B; Coroleu W; del Alcazar R; Hilbert P; Van Maldergem L; Pintos-Morell G
    Eur J Med Genet; 2009; 52(1):14-6. PubMed ID: 19041432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects.
    Fu M; Kazlauskaite R; Baracho Mde F; Santos MG; Brandão-Neto J; Villares S; Celi FS; Wajchenberg BL; Shuldiner AR
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2916-22. PubMed ID: 15181077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic basis of congenital generalized lipodystrophy.
    Agarwal AK; Barnes RI; Garg A
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):336-9. PubMed ID: 14557833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.
    Vatier C; Vantyghem MC; Storey C; Jéru I; Christin-Maitre S; Fève B; Lascols O; Beltrand J; Carel JC; Vigouroux C; Bismuth E
    Curr Med Res Opin; 2019 Mar; 35(3):543-552. PubMed ID: 30296183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome.
    Miranda DM; Wajchenberg BL; Calsolari MR; Aguiar MJ; Silva JM; Ribeiro MG; Fonseca C; Amaral D; Boson WL; Resende BA; De Marco L
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):512-7. PubMed ID: 19226263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital generalized lipodystrophy: profile of the disease and gender differences in two siblings.
    Raygada M; Rennert O
    Clin Genet; 2005 Jan; 67(1):98-101. PubMed ID: 15617555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of genetic suppressors for a BSCL2 lipodystrophy pathogenic variant in Caenorhabditis elegans.
    Bai X; Smith HE; Golden A
    Dis Model Mech; 2024 Jun; 17(6):. PubMed ID: 38454882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further delineation of AGPAT2 and BSCL2 related congenital generalized lipodystrophy in young infants.
    Liu Y; Li D; Ding Y; Kang L; Jin Y; Song J; Li H; Yang Y
    Eur J Med Genet; 2019 Sep; 62(9):103542. PubMed ID: 30266686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of mutations in AGPAT2 among human lipodystrophies.
    Magré J; Delépine M; Van Maldergem L; Robert JJ; Maassen JA; Meier M; Panz VR; Kim CA; Tubiana-Rufi N; Czernichow P; Seemanova E; Buchanan CR; Lacombe D; Vigouroux C; Lascols O; Kahn CR; Capeau J; Lathrop M
    Diabetes; 2003 Jun; 52(6):1573-8. PubMed ID: 12765973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization, cDNA sequence and genomic organization of the rat seipin gene (Bscl2) and sequence analysis in inbred rat models of Type 2 diabetes mellitus.
    Kaisaki PJ; Sebag-Montefiore LM; Brown JH; Magre J; Lathrop M; Capeau J; Gauguier D
    Cytogenet Genome Res; 2002; 98(1):71-4. PubMed ID: 12584444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the seipin and AGPAT2 genes clustering in consanguineous families with Berardinelli-Seip congenital lipodystrophy from two separate geographical regions of Brazil.
    Gomes KB; Fernandes AP; Ferreira AC; Pardini H; Garg A; Magré J; Pardini VC
    J Clin Endocrinol Metab; 2004 Jan; 89(1):357-61. PubMed ID: 14715872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment.
    Lupsa BC; Sachdev V; Lungu AO; Rosing DR; Gorden P
    Medicine (Baltimore); 2010 Jul; 89(4):245-250. PubMed ID: 20616664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency.
    Antuna-Puente B; Boutet E; Vigouroux C; Lascols O; Slama L; Caron-Debarle M; Khallouf E; Lévy-Marchal C; Capeau J; Bastard JP; Magré J
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1463-8. PubMed ID: 20097706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity for congenital generalized lipodystrophy in seventeen patients from Oman.
    Rajab A; Heathcote K; Joshi S; Jeffery S; Patton M
    Am J Med Genet; 2002 Jul; 110(3):219-25. PubMed ID: 12116229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 congenital generalized lipodystrophy with a heterozygous missense NOTCH2 mutation.
    Wang M; Cun Z; Peng J; Chen R; Li J
    Eur J Clin Nutr; 2022 Jul; 76(7):1041-1043. PubMed ID: 35043011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.